Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BBIO
#700
BridgeBio Pharma, Inc. - Common Stock
78.6
8
USD
-0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.87%
Monthly Change
-7.02%
6 month change
+22.25%
Year Change
+38.04%
Previous Close
79.3
7
Open
78.6
8
Low
78.6
8
High
78.6
8
Volume
121
Markets
US Stock Market
Healthcare
Biotechnology
BBIO
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2019
Current report, Q4 FY2019
2019.10.11
Bridgebio Pharma, Inc. current report, Q4 FY2019
8-K
Current report, Q3 FY2019
2019.09.12
Bridgebio Pharma, Inc. current report, Q3 FY2019
8-K
Current report, Q2 FY2019
2019.07.03
Bridgebio Pharma, Inc. current report, Q2 FY2019
8-K
1
...
5
6
7
8
9
10
11
12
News
BridgeBio Q2 Sales Jump 120% as Attruby Drives Commercial Momentum
Is BBIO a Buy as Fast Sales Growth Meets a Steep Valuation Premium?
Why BBIO Rose 24% in Three Months and Whether the Rally Can Continue
BridgeBio: Attruby Delivers In Q2, Expect Three New Launches In 12 Months (NASDAQ:BBIO)
BridgeBio Q2 Earnings Miss, Revenues Beat as Attruby Sales Surge
4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year
BridgeBio Pharma, Inc. (BBIO) Q2 2026 Earnings Call Transcript
BridgeBio Pharma (BBIO) Reports Q2 Loss, Tops Revenue Estimates
The Week That Was, The Week Ahead: Macro and Markets, August 9 - TipRanks.com
Viatris Gears Up to Report Q2 Earnings: What's in the Cards?
BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: Should You Buy?
Tracking Ole Andreas Halvorsen’s Viking Global Portfolio – Q1 2026 Update